Dear Valued Participant, Welcome to the Masters of Pediatric Dermatology Symposium (MOPD). In so many ways, this year’s conference is our most transformative and unparalleled yet. To begin, this marks the first year that MOPD will be delivered by LiVDerm, a leading medical education hub dedicated to revolutionizing dermatology education. Additionally, for the first time ever, the Masters of Pediatric Dermatology Symposium is being delivered entirely online. These new changes have allowed us to provide an expanded 1.5 days worth of advanced education—offering a more expansive look into the topics that are most relevant to dermatologic pediatric care. These topics include caring for skin of color, wound healing, COVID lesions, pediatric therapeutics, and much more across the spectrum of pediatric dermatology. The event is led by Symposium Chair, Dr. Lawrence Schachner, MD, a Professor of Pediatrics, and Co-Director of the Division of Pediatric Dermatology at the University of Miami, Miller School of Medicine. In partnership with a number of additional industry experts and academic educators, MOPD will provide advanced expertise on the latest treatment approaches, protocols, procedures, and tools in pediatric dermatology. As we enter this new season, we are grateful for your commitment to providing advanced, more personalized care to pediatric patients. On behalf of the entire LiVDerm Team, thank you for your time and dedication. In Good Health, The LiVDerm Team
2 www.livderm.org
www.livderm.org 3
AGENDA
THURSDAY
FEBRUARY 4, 2021 9:00 AM - 9:05 AM
Opening Remarks Lawrence A. Schachner, MD
9:05 AM - 9:35 AM
Bacterial Infections in Kids Adelaide A. Hebert, MD
9:35 AM - 10:05 AM
Pediatric Psoriasis 2021 Adelaide A. Hebert, MD
10:05 AM - 10:35 AM COVID Lesions in Children’s Skin Andrea Maderal, MD 10:35 AM - 11:00 AM Therapeutic Update 2021 Lawrence A. Schachner, MD 11:00 AM - 11:15 AM EXHIBIT BREAK 11:15 AM - 11:45 AM The Big Stories in Children’s Hair Disorders-2021 Antonella Tosti, MD 11:45 AM - 12:15 PM New Medications in Preteen Acne Jonette Keri, MD 12:15 PM - 12:45 PM Worrisome Pigmented Lesions in Children Fernanda Schmidt, MD 12:45 PM - 1:00 PM
EXHIBIT BREAK
1:00 PM - 2:00 PM
Lunch PME Symposium A Treatment Option for Patients with Uncontrolled Moderate-to-Severe Atopic Dermatitis Latanya Benjamin, MD, FAAD, FAAP Sponsored by Sanofi/Regeneron
2:00 PM - 2:15 PM
Active Stretch Session with NASM-Certified Fitness Instructor Aria Aloi
2:15 PM - 2:45 PM
Potentially Life-Threatening Vascular Lesions in Pediatric Dermatology Mercedes Gonzalez, MD
2:45 PM - 3:15 PM
Potentially Life-Threatening Dermatoses in Neonates & Infants Lawrence Eichenfield, MD
3:15 PM - 4:30 PM
Pediatric Wound Healing Symposium Robert Kirsner, MD Marjana Tomic Canic, MD Sundeep Keswani, MD
4:30 PM - 5:00 PM
Atopic Dermatitis Therapy Lawrence A. Schachner, MD
5:00 PM
Adjourn for the Day
This symposium is in partnership with the Wound Healing Society
www.livderm.org 5
FRIDAY
FEBRUARY 5, 2021 7:45 AM - 8:45 AM
PME Symposium AKLIEFÂŽ Cream: An Innovative Topical Retinoid for the Treatment of Acne Lawrence Eichenfield, M.D. Sponsored by Galderma
8:45 AM - 9:00 AM
EXHIBIT BREAK
9:00 AM - 10:00 AM
Pediatric Skin of Color Symposium Latanya Benjamin, MD Candrice Heath, MD This symposium is supported by education grants from Galderma & Incyte.
This symposium is in partnership with the the Skin Of Color Society (SOCS)
10:00 AM - 10:30 AM Life threatening Dermatoses in Children and Adolescents Lawrence Eichenfield, MD 10:30 AM - 11:00 AM Life threatening lumps and bumps in Ped-Derm Fernanda B. Schmidt, MD 11:00 AM - 12:30 PM
MOPD Therapeutic Master Class Vitilgo - Latanya Benjamin, MD Hyperhidosis - Adelaide A. Hebert, MD Alpoecia Areata - Lawrence A. Schachner, MD Molluscum - Lawrence Eichenfield, MD Verruca - Adelaide A. Hebert, MD Hemangioma - Mercedes Gonzalez, MD
12:30 PM - 12:45 PM Active Stretch Session with NASM-Certified Fitness Instructor Aria Aloi 12:45 PM - 1:30 PM
6 www.livderm.org
Lunch PME Symposium A Treatment Option for Mild-to-Moderate Atopic Dermatitis in Patients Aged 3 Months and Older Emily M. Becker, MD Sponsored by Pfizer, Inc. Eucrisa
EXPERT SPEAKERS
SYMPOSIUM CHAIR Lawrence A. Schachner, MD Professor and Chair Emeritus Dr. Phillip Frost Department of Dermatology & Cutaneous Surgery Professor Department of Pediatrics University of Miami Miller School of Medicine Miami, Florida
EXPERT FACULTY Latanya Benjamin, MD, FAAD, FAAP
Lawrence F. Eichefield, MD
Associate Professor of Pediatric Dermatology Florida Atlantic University Boca Raton, FL
Distinguished Professor of Dermatology & Pediatrics Departments of Dermatology and Pediatrics Vice Chair Department of Dermatology Chief, Pediatric and Adolescent Dermatology University of California San Diego, School of Medicine and Rady Children’s Hospital San Diego, CA
Mercedes Gonzalez, MD, FAAD
Candrice Heath, MD
Medical Director, Pediatric Dermatology of Miami Assistant Professor, University of Miami Miller School of Medicine, Dr. Phillip Frost Department of Dermatology and Herbert Wertheim College of Medicine Miami, FL
Assistant Professor (Adult and Pediatric Dermatology) Director, Pediatric Dermatology Lewis Katz School of Medicine, Temple University, Department of Dermatology Philadelphia, PA
www.livderm.org 7
EXPERT FACULTY Adelaide A. Hebert, MD
Jonette E. Keri, MD, MPH
Professor of Dermatology and Pediatrics UTHealth McGovern Medical School Houston, TX
Associate Professor University of Miami Philip Frost Department of Dermatology and Cutaneous Surgery Dermatology Service Chief, Miami VA Hospital Miami, FL
Robert Kirsner, MD
Andrea D. Maderal, MD
Chairman and Harvey Blank Professor University of Miami Miami, FL
Assistant Professor, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery University of Miami Miller School of Medicine Miami, FL
Keswani Sundeep, MD, FACS, FAAP
Marjana Tomic-Canic, PhD
Chief of Pediatric Surgery Surgical Director of Basic Science Research, Texas Children’s Hospital Clayton Endowed Chair in Surgical Research Professor of Surgery, Pediatrics, and Obstetrics, Baylor College of Medicine Houston, TX
Director, Wound Healing and Regenerative Medicine Research Program Professor and Vice Chair of Research University of Miami Miller School of Medicine Miami, FL
Antonella Tosti, MD Fredric Brandt Endowed Professor of Dermatology Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery University of Miami Miller School of Medicine Miami, FL
8 www.livderm.org
nce a h c e h t e for m a g r u ch, t o a n i W t e r l a p d, Ap Take p a P i e l p p A to win an ar Pods! E or Apple
Y D A E R R SOME FO ? N FU
THE MORE YOU ENGAGE
with the activities listed below, the more points you'll gain, and the greater chance you have of winning big. GOOD LUCK!
• Join a virtual trade show live meeting
Every time
10 pts
• Participate in a group video meeting
Every time
10 pts
• Watch a webinar
Every time
10 pts
• Request info from Exhibitor
Every time
10 pts
• Watch exhibitor/sponsor videos
Every time
10 pts
• Download exhibitor/sponsor files
Every time
10 pts
• Add a session to your agenda
Every time
10 pts
• Post photo in forum
Only once
10 pts
• Send private message
Every time
10 pts
• Post message in discussion
Every time
10 pts
• Participate in poll
Every time
10 pts
• Add profile photo
Only once
10 pts
Masters of Pediatric Dermatology 2021 February 4-5, 2021
ACTIVITY OVERVIEW The annual Master’s of Pediatric Dermatology Symposium (MOPD) is a one and half-day session was initially developed to promote and advance education surrounding skin diseases & disorders in pediatric age groups, and to foster an exchange of information between physicians and health professionals interested in the field of pediatric dermatology. This year’s MOPD Symposium will allow attendees to learn the latest treatment approaches, protocols, procedures, and tools needed to support children with dermatologic conditions, and ultimately provide better, more personalized care for this specific population of younger patients. TARGET AUDIENCE The Masters of Pediatric Dermatology symposium is designed to meet the needs of pediatric dermatologists, pediatricians, family practitioners, dermatologists, nurses/nurse practitioners and residents in these programs. Learning Objectives Upon completion of the educational activity, participants should be able to: • Identify effective patient/caretaker communication and education strategies to improve patient adherence to prescribed therapy for chronic dermatologic conditions. • Choose appropriate therapy for psoriasis in children and adolescents based on disease severity and available evidence. • List recent advances in pediatric atopic dermatitis knowledge and treatment. • Examine the efficacy and safety of current non-pharmacological and pharmacological treatments for AD patients across the age spectrum. • Select appropriate therapies for treatment of acne in children from newborns to preteens. • Identify therapeutic advances for pigmented lesions and vitiligo in the pediatric population. • Discuss recent therapeutic updates for hyperhidrosis, impetigo, acne, and molluscum in pediatric population. • Select appropriate therapy for childhood hair loss disorders such as alopecia areata based on diagnosis and available evidence behind current and emerging treatments. • Discuss recent research into the treatment of cutaneous warts and molluscum contagiosum. • Choose appropriate therapy for management and treatment of epidermolysis bullosa. CRITERIA FOR SUCCESS Statements of credit will be awarded based on the participant’s attendance and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at www.southbeachsymposium. org. You must participate in the entire activity to receive credit. If you have questions about this CE activity, please contact AKH Inc. at tbrignoni@akhcme.com. Credit provided by AKH Inc., Advancing Knowledge in Healthcare In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Tarsus Cardio dba LiVDerm. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. This activity was planned by and for the healthcare team, and learners will receive 9.75 Interprofessional Continuing Education (IPCE) credit for learning and change. Physician AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 9.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurse 9.75 ANCC contact hours Physician Assistant AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 9.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. COMMERCIAL SUPPORT This activity is supported by educational grants from Almirall, LLC, Arcutis Biotherapeutics, Inc., Castle Creek, Galderma Laboratories, L.P., Incyte Corporation, Pfizer Inc., Sanofi Genzyme and Regeneron Pharmaceuticals, Verrica Pharmaceuticals Inc.
10 www.livderm.org
DISCLOSURE It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
DISCLOSURES NAME
RELATIONSHIP
COMPANY
Lawrence Eichenfield, MD
Consultant
Verrica
Mercedes Gonzalez, MD
Consultant
Pfizer, Regeneron Pharmaceuticals, Sanofi-Genzyme, Unilever, Inc, Verrica Pharmaceuticals
Contracted Research
Abbvie, Arcutis, Krystal Biotech, Inc, Novan, Pfizer, Regeneron Pharmaceuticals, Sanofi-Genzyme, Verrica, Inc
Speakers Bureau
Galderma, Pfizer, Regeneron Pharmaceuticals, Sanofi-Genzyme
Candrice Heath, MD, FAAP, FAAD
Consultant (Advisory Board)
Cassiopea, Inc.
Adelaide Hebert, MD
Consultant
Almirall, Dermatologics, Galderma, GlaxoSmithKline, Leo, Mayne, Ortho Arcutis, Pfizer, Verrica
Contracted Research
Allergan, Brickell, Demira (all monies paid to the medical school)
Speakers Bureau
Alriall, Arcutis, Galderma, GlaxoSmithKline, Leo, Mayne, Ortho Dermatologics, Pfizer, Verrica
Sundeep Keswani, MD, FACS, FAAP
N/A
Nothing to disclose
Robert Kirsner, MD, PhD
N/A
Nothing to disclose
Andrea Maderal, MD
N/A
Nothing to disclose
Lawrence Schachner, MD
N/A
Nothing to disclose
Fernanda Schmidt, MD
N/A
Nothing to disclose
Marjana Tomic-Canic, PhD
N/A
Nothing to disclose
Antonella Tosti, MD
Consultant
Almirall, Bristol Myers Squibb, DS Laboratories, Leo Pharmaceuticals, Lilly, Monat Global, P&G, Tirthy Madison
Dorothy Caputo, MA, BSN, RN - CE Director of Accreditations
N/A
Nothing to disclose
LiVDerm Planners and Reviewers
N/A
Nothing to disclose
AKH Planners and Reviewers
N/A
Nothing to disclose
All of the relevant financial relationships listed for these individuals have been mitigated. DISCLAIMER This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content. DISCLOSURE OF UNLABELED USE AND INVESTIGATIONAL PRODUCT This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
www.livderm.org 11
PROFESSIONAL MEDICAL EDUCATION Thursday February 4th 1:00pm - 2:00pm EST.
A Treatment Option for Patients with Uncontrolled Moderate-to-Severe Atopic Dermatitis Presented By: Latanya Benjamin, MD, FAAD, FAAP Provided by: Regeneron and Sanofi Genzyme Learn more about a treatment that may help your appropriate atopic dermatitis patients with uncontrolled moderateto-severe atopic dermatitis.
Friday February 5th 8:00am - 9:00am EST.
AKLIEFÂŽ Cream: An Innovative Topical Retinoid for the Treatment of Acne Presented By: Lawrence Eichenfield, MD Provided by: Galderma 52% of people with facial acne also have truncal acne.1 No topical therapy has been studied in robust clinical trials for truncal acne until now. Please join this virtual presentation to learn about an innovative retinoid that is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. 1. Del Rosso, JQ et al. J Drugs Dermatol. 2007;6(6):597-600.
Friday February 5th
12:30pm - 1:15pm EST. A Treatment Option for Mild-to-Moderate Atopic Dermatitis in Patients Aged 3 Months and Older Presented By: Emily M. Becker, MD Driscoll Children’s Hospital Assistant Clinical Professor in Dermatology, University of Texas Health Science Center San Antonio, Texas Provided by: Pfizer, Inc Eucrisa Join us for an interactive presentation on a steroid-free topical therapy for the treatment of mild-to-moderate atopic dermatitis. Expert faculty will guide the audience through an in-depth look into the product and answer questions to help attendees gain a better understanding of this treatment option.
12 www.livderm.org
PROFESSIONAL
2. BRICKELL BIOTECH A Multi-Center, Open-Label Study to Assess the Long-term Safety/Tolerability, and Pharmacokinetics, and Explore the Efficacy of Sofpironium Bromide Gel, 15% Applied Topically to Children and Adolescents, 9 to 16 Years of Age, with Primary Axillary Hyperhidrosis Brandon Kirsch, MD1, Janet DuBois, MD2, Martin N. Zaiac, MD3, Deepak Chadha, MS, MBA, RAC1, Sanjeev Ahuja, MD, MBA, FACP1
8. CASTLE CREEK BIOSCIENCES A Phase 3 Randomized Trial to Determine the Safety and Efficacy of FCX-007 for the Treatment of Wounds Associated with Recessive Dystrophic Epidermolysis Bullosa (RDEB)
M. Yonchek, R. Blumenthal, M. Spellman; Castle Creek Biosciences, Exton, PA
10. DERMIRA Hyperhidrosis Affects Multiple Focal Areas and Is Undertreated in Pediatric Sufferers: Survey Results from Population of >500 Children and Adolescents Z. P. Rice,a R. Sidbury,b L.J. Pieretti,c, T. Devlin, d K.K. Gillard,d , D. Comoroda,e M. Kosinski,e and A.A. Hebertf
13. DR. PHILLIP FROST DEPT OF DERMATOLOGY & CUTANEOUS SURGERY
Loose Anagen and Short Anagen Syndrome Registry: Establishment and Future Prospects
aEran C. Gwillim, MD, aMichael J. Randolph, BS, and aAntonella Tosti, MD
16. MAYNE PHARMA
Evaluation of Halobetasol Propionate Foam in Adolescents with Plaque Psoriasis
Adelaide Hebert MDa; Lawrence Eichenfield MDb; Rhonda Schreiber MSRNc
Evaluation of Calcipotriene Foam in Pediatric Patients with Plaque Psoriasis
17. MAYNE PHARMA Adelaide A. Hebert, MD, The UT Health McGovern Medical school-Houston, Houston, Texas; Rhonda Schreiber MSRN
24. VERRICA The Hidden Impact of Molluscum Contagiosum: Survey of Caregivers’ Experiences with Diagnosis and Management
Pearl Kwong1, Adelaide Hebert2, Collette Utley3, Melissa Olivadoti4
www.livderm.org 13
The 2021 MOPD Symposium gratefully acknowledges its partners:
The Masters of Pediatrics Dermatology (MOPD) gratefully acknowledges the independent grant support received from:
MOPD General Support • Almirall • Arcutis • Castle Creek • Galderma
MOPD Satellite Symposia • Incyte • Pfizer • Sanofi/Regeneron • Verrica
• Galderma • Incyte
www.livderm.org 15
Non Educational Content
SEE WHAT’S POSSIBLE WITH ® DUPIXENT (dupilumab) Explore the possibilities at DupixentHCP.com
DUPIXENT® is a registered trademark of Sanofi Biotechnology. ©2020 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.
10/2020
DUP.20.10.0043
SEE WHAT’S POSSIBLE WITH ® DUPIXENT (dupilumab) Explore the possibilities at DupixentHCP.com
DUPIXENT® is a registered trademark of Sanofi Biotechnology. ©2020 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.
10/2020
DUP.20.10.0043
The 2021 MOPD Symposium gratefully acknowledges the following level sponsors:
GOLD
SILVER
BRONZE
GENERAL SUPPORT
www.livderm.org 19
where the constellation of medical dermatology and aesthetics collide.
UPCOMING
Live & Virtual Meetings
Racial Disparities in Dermatology
Dermatology on the Frontlines
MARCH 6, 2021
APRIL 24, 2021
Complimentary REGISTRATION
PART II THE AESTHETIC DERMATOLOGY Summit | SEPTEMBER 23 - 25, 2021 | THE DIPLOMAT RESORT HOLLYWOOD, FL AN ADVANCED IN-PERSON EDUCATIONAL EXPERIENCE FOR THE BOOKS.
For more information visit www.livderm.org or call 561-893-8625